694 related articles for article (PubMed ID: 33482113)
41. Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.
Gross TG; Hale GA; He W; Camitta BM; Sanders JE; Cairo MS; Hayashi RJ; Termuhlen AM; Zhang MJ; Davies SM; Eapen M
Biol Blood Marrow Transplant; 2010 Feb; 16(2):223-30. PubMed ID: 19800015
[TBL] [Abstract][Full Text] [Related]
42. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
43. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.
Serio B; Giudice V; Guariglia R; Fontana R; Pezzullo L; Martorelli MC; Ferrara I; Mettivier L; D'Addona M; Vaccaro E; Langella M; Selleri C
Infez Med; 2021 Mar; 29(1):102-113. PubMed ID: 33664179
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002.
Kasow KA; King E; Rochester R; Tong X; Srivastava DK; Horwitz EM; Leung W; Woodard P; Handgretinger R; Hale GA
Biol Blood Marrow Transplant; 2007 Jul; 13(7):831-7. PubMed ID: 17580261
[TBL] [Abstract][Full Text] [Related]
45. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
Girmenia C; Bertaina A; Piciocchi A; Perruccio K; Algarotti A; Busca A; Cattaneo C; Raiola AM; Guidi S; Iori AP; Candoni A; Irrera G; Milone G; Marcacci G; Scimè R; Musso M; Cudillo L; Sica S; Castagna L; Corradini P; Marchesi F; Pastore D; Alessandrino EP; Annaloro C; Ciceri F; Santarone S; Nassi L; Farina C; Viscoli C; Rossolini GM; Bonifazi F; Rambaldi A;
Clin Infect Dis; 2017 Nov; 65(11):1884-1896. PubMed ID: 29020286
[TBL] [Abstract][Full Text] [Related]
46. Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study.
Gadalla SM; Wang Y; Wang T; Onabajo OO; Banday AR; Obajemu A; Karaesman E; Sucheston-Campbell L; Hahn T; Sees JA; Spellman SR; Lee SJ; Katki HA; Prokunina-Olsson L
Lancet Haematol; 2020 Oct; 7(10):e715-e723. PubMed ID: 32976751
[TBL] [Abstract][Full Text] [Related]
47. Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomes.
Tinianow A; Gay JC; Bearl DW; Connelly JA; Godown J; Kitko CL
Pediatr Transplant; 2020 Aug; 24(5):e13748. PubMed ID: 32485042
[TBL] [Abstract][Full Text] [Related]
48. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005.
Youssef S; Rodriguez G; Rolston KV; Champlin RE; Raad II; Safdar A
Medicine (Baltimore); 2007 Mar; 86(2):69-77. PubMed ID: 17435587
[TBL] [Abstract][Full Text] [Related]
49. The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Kako S; Izutsu K; Kato K; Kim SW; Mori T; Fukuda T; Kobayashi N; Taji H; Hashimoto H; Kondo T; Sakamaki H; Morishima Y; Kato K; Suzuki R; Suzumiya J;
Am J Hematol; 2015 Feb; 90(2):132-8. PubMed ID: 25382792
[TBL] [Abstract][Full Text] [Related]
50. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
Lazarus HM; Zhang MJ; Carreras J; Hayes-Lattin BM; Ataergin AS; Bitran JD; Bolwell BJ; Freytes CO; Gale RP; Goldstein SC; Hale GA; Inwards DJ; Klumpp TR; Marks DI; Maziarz RT; McCarthy PL; Pavlovsky S; Rizzo JD; Shea TC; Schouten HC; Slavin S; Winter JN; van Besien K; Vose JM; Hari PN
Biol Blood Marrow Transplant; 2010 Jan; 16(1):35-45. PubMed ID: 20053330
[TBL] [Abstract][Full Text] [Related]
51. Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.
Holter Chakrabarty JL; Rubinger M; Le-Rademacher J; Wang HL; Grigg A; Selby GB; Szer J; Rowe JM; Weisdorf DJ; Tallman MS
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1021-5. PubMed ID: 24691221
[TBL] [Abstract][Full Text] [Related]
52. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
[TBL] [Abstract][Full Text] [Related]
53. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
Fabiani S; Fortunato S; Petrini M; Bruschi F
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
[TBL] [Abstract][Full Text] [Related]
54. Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Alzahrani M; Power M; Abou Mourad Y; Barnett M; Broady R; Forrest D; Gerrie A; Hogge D; Nantel S; Sanford D; Song K; Sutherland H; Toze C; Nevill T; Narayanan S
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1209-1215. PubMed ID: 29474870
[TBL] [Abstract][Full Text] [Related]
55. Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.
Jaime-Pérez JC; Villarreal-Villarreal CD; Méndez-Ramírez N; Vázquez-Garza E; Salazar-Riojas R; Gómez-Almaguer D
Blood Cells Mol Dis; 2016 May; 58():52-6. PubMed ID: 27067489
[TBL] [Abstract][Full Text] [Related]
56. Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group.
Shinohara A; Oshima K; Fuji S; Umeda K; Kako S; Kurokawa M; Tsukada N; Kasai M; Kondo T; Hashii Y; Nakamae H; Ikegame K; Kosaka Y; Shimada A; Nawa Y; Makoto Y; Yoshiko A; Fukuda T; Tanaka J; Ogata M
Biol Blood Marrow Transplant; 2020 Jan; 26(1):66-75. PubMed ID: 31494230
[TBL] [Abstract][Full Text] [Related]
57. Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic.
Mir MA; Kapoor P; Kumar S; Pandey S; Dispenzieri A; Lacy MQ; Dingli D; Hogan W; Buadi F; Hayman S; Gandhi M; Gertz MA
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):349-357.e2. PubMed ID: 25958193
[TBL] [Abstract][Full Text] [Related]
58. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research.
Bishop MR; Logan BR; Gandham S; Bolwell BJ; Cahn JY; Lazarus HM; Litzow MR; Marks DI; Wiernik PH; McCarthy PL; Russell JA; Miller CB; Sierra J; Milone G; Keating A; Loberiza FR; Giralt S; Horowitz MM; Weisdorf DJ
Bone Marrow Transplant; 2008 Apr; 41(7):635-42. PubMed ID: 18084335
[TBL] [Abstract][Full Text] [Related]
59. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
[TBL] [Abstract][Full Text] [Related]
60. Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT.
Giebel S; Labopin M; Potter M; Poiré X; Sengeloev H; Socié G; Huynh A; Afanasyev BV; Schanz U; Ringden O; Kalhs P; Beelen DW; Campos AM; Masszi T; Canaani J; Mohty M; Nagler A
Eur J Cancer; 2018 Jun; 96():73-81. PubMed ID: 29679774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
